The ReNew brand was developed to meet the growing demand for more sustainable Omega-3 human health products, animal nutrition products, and biofuel feedstocks.
The portfolio is comprised of four main product categories:
1 – Omega-3
Compelling scientific evidence continues to show the health benefits of a diet rich in the
Omega-3 fatty acids EPA and DHA. This has led to an increase in worldwide consumption of fish and fish oils – the main sources of Omega-3 EPA and DHA oils currently.
However, unknown to many, fish that contain these valuable Omega-3 fatty acids get them from eating microalgae – the original source of Omega-3s in the ocean – or other fish that have consumed microalgae.
Cellana’s line of Omega-3 products includes ReNew EPA and ReNew DHA. These products enable producers to “Cut Out The Middle Fish” and supply renewable, more sustainable, and vegetarian Omega-3 products without contributing to potential overfishing or exposure to fish-based pollutants such as mercury, dioxins, and PCBs.
Feed
This product leverages algae’s ability to enhance the nutritional value of feed and provide an alternative, more sustainable, high-protein feed source for the aquaculture and animal feed markets.
Multiple ReNew Feed feeding trials for finfish, shellfish, pigs, chickens, and cattle, among other species of farmed animals, have been ongoing since 2010 in the United States, Europe, and Asia.
Fuel
Algae-based biocrude applications provide renewable, sustainable, and economic alternatives for transportation fuels, particularly jet fuels for commercial and military aircraft.
ReNew Fuel is currently being tested by major energy companies, as well as by large-scale producers and refiners of petroleum-based fuels and biofuels from crop-based feedstocks.
Algae
Algal biomass consists of natural oils, proteins, and carbohydrates from which many valuable products can be derived for human nutrition, animal nutrition, and biofuel applications.
ReNew Algae, grown from selected microalgae strains, is available in bulk for customers to apply their own extraction technologies and develop customized solutions within these application areas.
This technology, refined at Cellana’s six-acre Kona Demonstration Facility on Hawaii’s Big Island, has produced more than nine tons of algal biomass for commercial testing.
Cellana grows its algae photosynthetically – powered by sunlight – without dependence on sugar crops, which are required for competitors’ fermentation-based technologies.
Since the microalgae are grown in salt or brackish water, freshwater use is minimized, enabling to help preserve this valuable resource.
Multiple facilities planned
Cellana is planning to establish off-take agreements for its line of products and then deploy multiple commercial facilities around the world to satisfy these off-take agreements.
Samples are currently being shipped to potential customers in the animal nutrition and biofuel industries, with the Omega-3 product samples anticipated to be available for testing by potential customers in the second half of 2012.
To date, over $100 million has been invested in developing Cellana’s algae strains, patented and proprietary production technologies, and its Kona Demonstration Facility.